Statistics
Publications
20
Citations
1.4K
H-Index
17
Active since
2000
Jeffrey Skolnik is an author at AstraZeneca (United States) specializing in oncology, medicine, and molecular oncology.
Publications per year
2000–2022
20
20
Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design
Jeffrey Skolnik, Jeffrey S. Barrett, Bhuvana Jayaraman et al. · Journal of Clinical Oncology · 2008 · 267 citations · Full text
Medicine, Oncology, Pediatrics +17
Antitumor Activity in <i>RAS</i> -Driven Tumors by Blocking AKT and MEK
Anthony W. Tolcher, Khurum Khan, Michael Ong et al. · Clinical Cancer Research · 2014 · 137 citations · Full text
Medicine, Oncology, Pharmacology +16
Roberto Chiarle, Yan Fan, Roberto Piva et al. · American Journal Of Pathology · 2002 · 110 citations · Full text
1–5 of 20